- From: <kc28@email.med.yale.edu>
- Date: Sun, 25 May 2008 22:41:11 -0400
- To: Tim Clark <twclark@nmr.mgh.harvard.edu>
- Cc: "M. Scott Marshall" <marshall@science.uva.nl>, public-semweb-lifesci@w3.org
Hi Tim et al., I think it would be great if more details about SWAN can be added. The HCLS ecosystem consists of scientists, patients, doctors, government agencies, publishers, etc. Creating/maintaining a balance in this digital age across national boundaries is challenging/interesting. Speaking of national boundaries, I wonder if alternative medicine (e.g., herbal medicine) would also be of interest to this community. For example, Huperzine is a drug derived from the herb Huperzia serrata. I also wonder if there are hypotheses regarding the study of herbs in the possible treatment of neurological diseases. Thanks, -Kei Quoting Tim Clark <twclark@nmr.mgh.harvard.edu>: > > Hi Scott, > > Your KB note lists no details about SWAN - we would like to see them > included. I'll forward something to you in a separate email later > today. > > Best > > Tim > > Tim Clark > Director of Informatics, MassGeneral Institute for Neurodegenerative > Disease > Instructor in Neurology, Harvard Medical School > 617-947-7098 (mobile) > > On May 23, 2008, at 6:59 PM, M. Scott Marshall wrote: > > > > > The KB note is ready for a last round of feedback and corrections. > > We have until the end of the month to publish so please be speedy > > with feedback. You can view the Editor's working draft at: > http://www.w3.org/2001/sw/hcls/notes/kb/ > > > > Thanks, > > Scott > > > > -- > > M. Scott Marshall > > tel. +31 (0) 20 525 7522 > > http://staff.science.uva.nl/~marshall > > http://adaptivedisclosure.org > > > > > > > > > > > >
Received on Monday, 26 May 2008 02:41:58 UTC